Kaichun Li

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Transforming Growth Factor

Walled Carbon Nanotubes

Top Venues

Thoracic cancer

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Li, Jing Chen, Jing Sun, Kaichun Li
The Formation of NETs and Their Mechanism of Promoting Tumor Metastasis. Journal of oncology 2023 (2023)
Ling-Zhijie Kong, Ying Zheng, Kaichun Li
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report. Immunotherapy 16 (2) (2023)
Jian Li, Jing Chen, Jing Sun, Kaichun Li
The Formation of NETs and Their Mechanism of Promoting Tumor Metastasis. Journal of oncology 2023 (2023)
Ling-Zhijie Kong, Ying Zheng, Kaichun Li
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report. Immunotherapy 16 (2) (2023)
Ling-Zhijie Kong, Ying Zheng, Kaichun Li
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report. Immunotherapy (2023)
Wenyan Yu, Zhuning Wang, Ping Dai, Jing Sun, Jian Li, Wei Han, Kaichun Li
The activation of SIRT1 by resveratrol reduces breast cancer metastasis to lung through inhibiting neutrophil extracellular traps. Journal of drug targeting (2023)
Jian Li, Ping Dai, Jing Sun, Wenyan Yu, Wei Han, Kaichun Li
FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer. Thoracic cancer (2022)
Jian Li, Ping Dai, Jing Sun, Wenyan Yu, Wei Han, Kaichun Li
FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer. Thoracic cancer 14 (4) (2022)
Kaikai Zheng, Dong Zhou, Lili Wu, Jian Li, Bing Zhao, Shihao Zhang, Ruiying He, Lan Xiao, Iqbal Zoya, Li Yu, Yuhong Zhang, Yulin Li, Jie Gao, Kaichun Li
K. ZHENG ET AL.Gold-nanoparticle-based multistage drug delivery system for antitumor therapy. Drug delivery 29 (1) (2022)
Jian Li, Ping Dai, Jing Sun, Wenyan Yu, Wei Han, Kaichun Li
FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer. Thoracic cancer 14 (4) (2022)
Jian Li, Ping Dai, Jing Sun, Wenyan Yu, Wei Han, Kaichun Li
FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer. Thoracic cancer 14 (4) (2022)